Recurrent Ovarian Cancer
When Cancer Returns — Treatment Options and Hope
What is Recurrent Ovarian Cancer?
Recurrent ovarian cancer means:
This may occur:
- After months or years
- Even after complete response to first treatment
What is Recurrent Ovarian Cancer?
Recurrent ovarian cancer means:
This may occur:
After months or years
Even after complete response to first treatment
Cancer has come back after initial treatment
Where Can Recurrence Occur?
Dr Swati Shah, MS, DNB — Robotic UroGynec Oncosurgeon, performs secondary cytoreductive surgery for recurrent ovarian cancer at Apollo Hospital, Bhat, Gandhinagar.
What is recurrent ovarian cancer?
Recurrent ovarian cancer is disease that returns after first-line surgery and chemotherapy, usually found on a rising CA-125 or on a scan.
Can surgery be done again for recurrent ovarian cancer?
Yes. Secondary cytoreductive surgery is offered when the recurrence is limited, the patient is fit, and complete removal of visible disease looks achievable.
What does platinum-sensitive recurrence mean?
Recurrence more than six months after platinum chemotherapy is called platinum-sensitive, and these patients gain the most from repeat surgery followed by chemotherapy.
Who performs recurrent ovarian cancer surgery in Ahmedabad?
Dr Swati Shah, MS, DNB — Robotic UroGynec Oncosurgeon, performs secondary cytoreductive surgery for recurrent ovarian cancer at Apollo Hospital, Bhat, Gandhinagar.
What does surgery for recurrent ovarian cancer cost in India?
Ovarian cytoreduction, including surgery for recurrence, is in the range of ₹2,50,000 to ₹5,00,000.
How is recurrent ovarian cancer followed up afterwards?
Follow-up combines clinical examination, CA-125 testing and CT imaging, timed to the pattern and interval of the earlier recurrence.
Recurrence of Ovarian Cancer
Recurrence does not mean no treatment is possible
Many patients can achieve:
- Long-term disease control
- Good quality of life
In selected cases, aggressive treatment can significantly improve outcomes
Understanding Recurrence
Ovarian cancer tends to:
- Remain a surface disease
- Recur along peritoneal surfaces
Similar principles of treatment apply again
Evaluation After Recurrence
Imaging Studies
CT Scan / PET Scan
Tumour Markers
CA-125 Assessment
Assessment Includes
- Extent of disease
- Patient fitness
Secondary Cytoreductive Surgery (Secondary CRS)
International Guidelines
Goal
Complete removal of all visible recurrent disease
Improves Survival
Delays Further Recurrence
May Reduce Need For Prolonged Chemotherapy
Chemotherapy & Platinum Sensitivity
Chemotherapy
Platinum Sensitivity
Targeted Therapy
BRCA Mutation
HRD Testing
Personalized Treatment Planning
Treatment depends on:
Prognosis
Life After Recurrence
Treatment is not decided only before surgery How Treatment is Planned
Final decisions are made during surgery using:
- Resection without rupture
- Frozen section (LIVE biopsy)
This allows:
Right surgery to be performed in a single operation
Why Biopsy Should Be Avoided Before Surgery
In most ovarian masses, preoperative biopsy is NOT recommended
1. Risk of Tumour Rupture
- Needle biopsy can puncture the cyst/tumour
- Leads to spillage → cancer spread
2. Does Not Change Treatment Plan
- If biopsy shows cancer → surgery is still required
- If biopsy shows no cancer → not reliable (only small sample taken)
3. False Reassurance Risk
- A negative biopsy does NOT rule out cancer
Why Choose a Comprehensive Ovarian Cancer Centre?
Management of recurrent ovarian cancer requires specialized expertise, careful patient selection, access to advanced therapies, and multidisciplinary planning.
Essential Requirements
- Expertise in secondary CRS
- Careful patient selection
- Access to advanced therapies
- Multidisciplinary planning
- Correct identification of surgical candidates
- Complete tumour removal when feasible
- Personalized treatment strategies
- Better long-term outcomes
Lets be Informed
Google Reviews
Read real stories from patients across India who trusted our specialized surgical protocols for their recovery.
- Knowledge Shorts
Watch our expert-curated shorts for quick, clear answers on diagnosis, treatment & more.
- Video testimonials
Video testimonials feature satisfied patients and clients sharing authentic stories to build trust and credibility.
This inspiring video shares the remarkable success story of a cancer patient who underwent Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) under the expert care of Dr. Swati Shah, an esteemed Oncosurgeon in Ahmedabad. The patient’s family member narrates their challenging medical journey, explaining how they traveled from their hometown to seek advanced treatment upon learning about Dr. Shah’s profound clinical expertise. Following a comprehensive medical examination, the patient was diagnosed with advanced cancer. To effectively combat this severe condition, Dr. Shah successfully performed a complex, highly specialized procedure combining CRS and HIPEC.
Features an inspiring testimonial from a brave patient who successfully battled stage 3 ovarian cancer. Hailing from Modasa, Gujarat, the patient and her family share their challenging medical journey from the initial diagnosis to her ongoing recovery. After consulting multiple medical professionals, they found Dr. Swati Shah, a specialized Robotic Uro-Gynecological Onco-Surgeon based in Ahmedabad, who provided them with much-needed guidance, reassurance, and confidence to proceed. The patient’s primary treatment involved Cytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
- Case Summaries
Advanced Secondary Cytoreductive Surgery and Splenectomy for Recurrent Ovarian Carcinoma
- The Challenge
- Managing Complex Recurrent Ovarian Cancer
A sixty-year-old female presented with a highly complex recurrence of stage IIIc ovarian cancer following previous treatments. Advanced imaging revealed challenging metastatic nodules deeply infiltrating the splenic parenchyma and the delicate infrapyloric region. This aggressive recurrence demanded immediate and highly precise surgical intervention.
The Solution
⦿ Precision Cytoreduction and Splenectomy
Dr. Swati Shah performed an advanced secondary cytoreductive surgery, carefully executing a complex splenectomy and targeted infrapyloric nodule excision. Utilizing meticulous dissection techniques in the highly vascular splenic hilum, the team ensured the precise removal of visible metastatic disease.
» Surgical Highlights & Precision
• Advanced Cytoreduction: Secondary cytoreductive surgery and splenectomy were flawlessly executed to effectively target the recurring disease.
• Complex Anatomical Dissection: The delicate splenic hilum and surrounding highly vascular tissues were seamlessly and perfectly navigated.
• Patient Safety: Hemostasis was thoroughly achieved, ensuring absolute minimal blood loss and maintaining perfect hemodynamic stability.
• Oncological Clearance: Both the spleen and the targeted infrapyloric metastatic nodules were successfully and completely excised.
» The Outcome
⦿ Successful Recovery and Favorable Pathology
The patient experienced an exceptionally smooth postoperative recovery, becoming fully ambulatory very shortly after the highly complex operation. Comprehensive final histopathology reports quickly confirmed the successful removal of the metastatic ovarian carcinoma from the spleen and the infrapyloric nodule. She was discharged home safely with perfectly stable hemodynamics and optimally controlled postoperative pain.
» Dr. Swati Shah’s Insight
Tackling recurrent ovarian cancer requires absolute surgical precision and a deeply strategic anatomical approach. By meticulously performing this secondary cytoreduction, we safely eliminated the metastatic burden and gave her the strongest possible chance for extended survival.
Advanced Exploratory Laparotomy And Ureteric Reconstruction For Recurrent Ovarian Adenocarcinoma
- The Challenge
- Navigating Suspected Pelvic Recurrence
A 39-year-old female presented with severe abdominal pain one month after completing adjuvant chemotherapy for endometrioid ovarian adenocarcinoma. Scans revealed suspected highly aggressive recurrent deposits adhering to her left ureter, sigmoid colon, and major pelvic vessels. This complex presentation demanded immediate, highly specialized surgical intervention.
The Solution
⦿ Complex Pelvic Resection and Reconstruction
Dr. Swati Shah performed an extensive exploratory laparotomy featuring left pelvic nodal mass excision alongside advanced ureteric resection and reconstruction. The complex procedure seamlessly integrated retroperitoneal lymph node dissection and supracolic omentectomy utilizing real-time frozen section analysis. Her advanced surgical precision safely navigated critical pelvic vessels.
» Surgical Highlights & Precision
• Procedure: An advanced laparotomy was executed with simultaneous ureteric reconstruction over a DJ stent.
• Complex Anatomy: Pelvic lymph nodes firmly adhering to major blood vessels were meticulously and safely resected.
• Patient Safety: Excellent hemodynamic stability was maintained throughout the procedure to ensure a rapid postoperative recovery.
• Cancer Clearance: Final histopathology definitively confirmed that all resected surgical specimens were completely free of malignant cells.
» The Outcome
⦿ Favorable Pathology and Rapid Recovery
The patient experienced an exceptionally smooth postoperative recovery, walking shortly after the complex surgery and maintaining stable hemodynamics. Crucially, the final pathology revealed only benign therapy-related inflammatory changes with absolutely no evidence of metastatic disease in the nodes or omentum. She was safely discharged after seven days with perfectly stable functional vitals.
» Dr. Swati Shah’s Insight
Navigating a suspected recurrent pelvic mass requires tremendous anatomical precision to safely protect vital structures like the ureter. I am incredibly thrilled our aggressive reconstructive approach yielded benign final pathology, granting her profound peace of mind and excellent long-term survival.
Consult for Recurrent Ovarian Cancer
- Whether surgery is possible
- Best treatment strategy
- Long-term management plan
Recurrent Ovarian Cancer Treatment in Ahmedabad, Gujarat
Secondary Cytoreductive Surgery
Advanced Chemotherapy
Targeted Therapy
- Ahmedabad
- Gujarat
- Across India
Frequently Asked Questions
No. Recurrence is common, and further treatment is often effective.
Yes, in selected patients (secondary CRS).
Recurrence after a longer interval, which responds better to chemotherapy.
Yes, many patients achieve long-term control.
